Dr. David McGroarty is a board certified Gastroenterologist serving the Richmond community for more than twenty five years. He is a graduate of both Georgetown University College and Medical School. He received his postdoctoral training in Internal medicine and Gastroenterology at Thomas Jefferson University Hospital and Lankenau Hospital in Philadelphia. He then had the good fortune to start his GI practice in Richmond.
Dr. McGroarty has a general gastroenterology practice dealing with diseases of the esophagus, upper and lower GI tract as well as the liver and pancreas. In addition, he has a special interest in small bowel disease being one of the first gastroenterologists in Richmond to incorporate the use of a wireless capsule, a now commonplace procedure, to exam the small bowel. He remains one of the few gastroenterologists in Central Virginia performing deep enteroscopy allowing more accurate diagnoses and management of difficult to reach small bowel lesions often avoiding surgery or locating for the surgeon where the problem is.
Dr. McGroarty is part of a highly expert and practiced team of physicians and nurses skilled not just in colon cancer surveillance and treatment but in the management of all aspects of colonic disease including all types of colitis (infectious, inflammatory or diverticular) as well as the very troubling symptoms of irritable bowel disease. Only a gastroenterologist can offer this level of comprehensive care.
“Carefully listening to the patient and performing a focused exam remains the key to diagnosing their ailment.”
There have been great changes since Dr. McGroarty started practice. The development of diagnostic modalities and innovation in gastroenterology have been impressive and gratifying. He is proud to be part of the RGA group who has been on the cutting edge of these many improvements in patient diagnoses and treatment. The incidence of colon cancer has been decreasing as the result of improved equipment, more expertly trained gastroenterologists and advocacy for colon cancer screening. Chronic Hepatitis C is a serious disease afflicting millions of Americans which previously required prolonged and difficult therapy with a response rate of 50%. Now, in many cases, it is able to be treated for a shorter period with much better tolerance and a response rate of greater than 95%.
Dr.McGroarty is a member of the American Gastroenterology Association, American Society of Gastrointestinal Endoscopy and Richmond Academy of Medicine. He has served as Chief of Medicine for St.Lukes-Humana Hospital, Chairman of the Quality Assurance Committee for Coventry Health Care and as President of the Richmond Society of Internal Medicine.
Dr. McGroarty is married with four wonderful children, three of whom are pursuing careers in some aspect of healthcare. He “bleeds blue for the Georgetown Hoyas” and is a member of the Board of Advisors for the Nursing and Healthcare Studies School at Georgetown. He keeps fit running and hiking with his wife and tries to keep up with old friends and family.